Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1...

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA

PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/2, PALB2 or RAD51C/D mutations ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )

Novel COVID-19 vaccine for B-cell deficient patients

Prof Juliane Walz - University Hospital Tübingen, Tübingen, Germany

Novel COVID-19 vaccine for B-cell deficient patients ( Prof Juliane Walz - University Hospital Tübingen, Tübingen, Germany )

Paediatric cancer patients in LMICS faced significantly higher mortality risk...

Dr Muhammed Elhadi - University of Tripoli, Tripoli, Libya

Paediatric cancer patients in LMICS faced significantly higher mortality risk during the COVID-19 pandemic ( Dr Muhammed Elhadi - University of Tripoli, Tripoli, Libya )

FAP-targeted PET imaging in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA

FAP-targeted PET imaging in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )

FAP-targeted molecular radiotherapy in cancer patients

Prof Jérémie Calais - UCLA, Los Angeles, USA

FAP-targeted molecular radiotherapy in cancer patients ( Prof Jérémie Calais - UCLA, Los Angeles, USA )

Immune gene signatures for predicting response to neoadjuvant...

Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda...

Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC ( Dr Marta Casarrubios - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )

METNET: A phase II trial of metformin in patients with well differentiated...

Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil

METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours ( Dr João Glasberg - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )

Real-world increase in biomarker testing in lung cancer

Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda...

Real-world increase in biomarker testing in lung cancer ( Dr Virginia Calvo de Juan - Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain )

EGFR testing: Best practice for NSCLC patients with exon 20 insertions

Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari

EGFR testing: Best practice for NSCLC patients with exon 20 insertions ( Dr Antonio Passaro, Dr Umberto Malapelle and Dr Joshua Sabari )

ASCO GU 2022: Latest in mHSPC

Prof Eleni Efstathiou, Prof Karim Fizazi, Prof Kim Chi and Prof Matthew Smith

ASCO GU 2022: Latest in mHSPC ( Prof Eleni Efstathiou, Prof Karim Fizazi, Prof Kim Chi and Prof Matthew Smith )

Minimal residual disease in multiple myeloma

Prof Ola Landgren - University of Miami, Miami, USA

Minimal residual disease in multiple myeloma ( Prof Ola Landgren - University of Miami, Miami, USA )

ASCO GU 2022: PARP inhibitors in prostate and MAGNITUDE

Dr Neal Shore and Prof Kim Chi

ASCO GU 2022: PARP inhibitors in prostate and MAGNITUDE ( Dr Neal Shore and Prof Kim Chi )

More from ecancer